| Dec 18, 2025 |
Dec 19, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
27.5
|
-4,625,346
|
-46.11%
|
✗
|
- |
| Dec 18, 2025 |
Dec 19, 2025 |
Joustra Wouter
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 18, 2025 |
Dec 19, 2025 |
Levin Andrew David
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 19, 2025 |
Joustra Wouter
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 19, 2025 |
Levin Andrew David
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 5, 2025 |
Dec 9, 2025 |
Mahatme Sandesh
|
CFO |
Neutral |
27.5
|
-694,137
|
-100.00%
|
✗
|
- |
| Dec 5, 2025 |
Dec 9, 2025 |
Zuraw Qing Che
|
Chief Development Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 5, 2025 |
Dec 9, 2025 |
Kress Jean-Paul
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 28, 2025 |
Oct 30, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Sell |
15.0
|
-400,408
|
-33.93%
|
✗
|
$10.4M |
| Oct 23, 2025 |
Oct 27, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Sell |
16.3
|
-221,166
|
-15.78%
|
✗
|
$6.2M |
| Oct 20, 2025 |
Oct 22, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Sell |
17.5
|
-117,050
|
-2.67%
|
✗
|
$3.4M |
| Oct 17, 2025 |
Oct 21, 2025 |
Reprogrammed Interchange LLC
|
10% Owner |
Sell |
17.5
|
-37,533
|
-3.12%
|
✗
|
$1.1M |
| Oct 15, 2025 |
Oct 17, 2025 |
Reprogrammed Interchange LLC
|
10% Owner |
Sell |
17.5
|
-73,676
|
-5.76%
|
✗
|
$2.3M |
| Oct 15, 2025 |
Oct 17, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Sell |
15.0
|
-464,025
|
-3.24%
|
✗
|
$13.7M |
| Oct 10, 2025 |
Oct 15, 2025 |
Reprogrammed Interchange LLC
|
10% Owner |
Sell |
17.5
|
-96,657
|
-7.03%
|
✗
|
$3M |
| Oct 8, 2025 |
Oct 10, 2025 |
Reprogrammed Interchange LLC
|
10% Owner |
Sell |
17.5
|
-124,146
|
-8.28%
|
✗
|
$4.1M |
| Oct 6, 2025 |
Oct 8, 2025 |
Reprogrammed Interchange LLC
|
10% Owner |
Sell |
17.5
|
-98,387
|
-6.16%
|
✗
|
$3.6M |
| Oct 1, 2025 |
Oct 3, 2025 |
Reprogrammed Interchange LLC
|
10% Owner |
Sell |
17.5
|
-41,752
|
-2.55%
|
✗
|
$1.6M |
| Sep 18, 2025 |
Sep 22, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 16, 2025 |
Sep 18, 2025 |
Reprogrammed Interchange LLC
|
10% Owner |
Sell |
20.0
|
-447,278
|
-1.35%
|
✗
|
$688.9K |
| Sep 11, 2025 |
Sep 15, 2025 |
Reprogrammed Interchange LLC
|
10% Owner |
Sell |
17.5
|
-984,805
|
-2.88%
|
✗
|
$1.7M |
| Sep 8, 2025 |
Sep 10, 2025 |
Reprogrammed Interchange LLC
|
10% Owner |
Sell |
17.5
|
-1,263,647
|
-3.56%
|
✗
|
$2.5M |
| Sep 8, 2025 |
Sep 10, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 8, 2025 |
Sep 10, 2025 |
Reed Sarah Burgess
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 8, 2025 |
Reed Sarah Burgess
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 3, 2025 |
Sep 5, 2025 |
Reprogrammed Interchange LLC
|
10% Owner |
Sell |
17.5
|
-1,407,628
|
-3.82%
|
✗
|
$2.8M |
| Aug 27, 2025 |
Aug 29, 2025 |
Reprogrammed Interchange LLC
|
10% Owner |
Sell |
17.5
|
-1,417,998
|
-3.70%
|
✗
|
$2.8M |
| Aug 25, 2025 |
Aug 27, 2025 |
Reprogrammed Interchange LLC
|
10% Owner |
Sell |
17.5
|
-671,536
|
-1.72%
|
✗
|
$1.4M |
| Jul 17, 2025 |
Jul 30, 2025 |
Zuraw Qing Che
|
Chief Development Officer |
Neutral |
90.0
|
+937,080
|
100.00%
|
✗
|
- |
|
Jul 30, 2025 |
Zuraw Qing Che
|
Chief Development Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 16, 2025 |
Jul 18, 2025 |
Detheux Michel
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 16, 2025 |
Jul 18, 2025 |
Cumbo Alexander
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2025 |
Detheux Michel
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2025 |
Cumbo Alexander
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 9, 2025 |
Jul 10, 2025 |
Mahatme Sandesh
|
CFO |
Neutral |
90.0
|
+13,882,750
|
100.00%
|
✗
|
- |
|
Jul 10, 2025 |
Mahatme Sandesh
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 26, 2025 |
Jun 27, 2025 |
Kress Jean-Paul
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 27, 2025 |
Kress Jean-Paul
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2025 |
May 23, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2025 |
May 23, 2025 |
Resnick Joshua
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2025 |
May 23, 2025 |
Kalir Erez
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2025 |
May 23, 2025 |
Lundberg Sven Ante
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2025 |
May 23, 2025 |
Lubner David Charles
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2025 |
May 23, 2025 |
Beckman Daniella
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2025 |
May 23, 2025 |
Patterson Matthew R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2025 |
May 23, 2025 |
Namouni Fouad
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 6, 2025 |
May 7, 2025 |
ANG ROBERT
|
CEO |
Sell |
52.5
|
-2,361
|
-0.26%
|
✗
|
$1.3K |
| May 6, 2025 |
May 7, 2025 |
Chakraborty Tirtha
|
Chief Sci Off & Head Tech Ops |
Sell |
52.5
|
-876
|
-0.40%
|
✗
|
$490.6 |
| May 1, 2025 |
May 2, 2025 |
Choi Han Wook
|
CFO |
Sell |
47.5
|
-2,061
|
-3.86%
|
✗
|
$1.4K |
| May 1, 2025 |
May 2, 2025 |
Chakraborty Tirtha
|
Chief Sci Off & Head Tech Ops |
Sell |
50.0
|
-1,947
|
-0.88%
|
✗
|
$1.3K |
| May 1, 2025 |
May 2, 2025 |
ANG ROBERT
|
CEO |
Sell |
50.0
|
-5,273
|
-0.57%
|
✗
|
$3.5K |
| Feb 13, 2025 |
Feb 18, 2025 |
Attar Eyal C.
|
CHIEF MEDICAL OFFICER |
Sell |
50.0
|
-2,227
|
-1.73%
|
✓
|
$3.2K |
| Feb 10, 2025 |
Feb 12, 2025 |
Attar Eyal C.
|
CHIEF MEDICAL OFFICER |
Sell |
50.0
|
-2,554
|
-1.94%
|
✓
|
$3.5K |
| Feb 6, 2025 |
Feb 7, 2025 |
Chakraborty Tirtha
|
CHIEF SCIENTIFIC OFFICER |
Sell |
52.5
|
-1,033
|
-0.47%
|
✗
|
$1.5K |
| Feb 6, 2025 |
Feb 7, 2025 |
ANG ROBERT
|
CEO |
Sell |
52.5
|
-2,787
|
-0.30%
|
✗
|
$4.2K |
| Feb 6, 2025 |
Feb 7, 2025 |
Attar Eyal C.
|
CHIEF MEDICAL OFFICER |
Sell |
50.0
|
-1,180
|
-0.89%
|
✗
|
$1.8K |
| Feb 3, 2025 |
Feb 5, 2025 |
ANG ROBERT
|
CEO |
Sell |
90.0
|
+134,252
|
17.05%
|
✗
|
$4.4K |
| Feb 3, 2025 |
Feb 5, 2025 |
Chakraborty Tirtha
|
CHIEF SCIENTIFIC OFFICER |
Sell |
90.0
|
+51,337
|
30.21%
|
✗
|
$1.6K |
| Feb 3, 2025 |
Feb 5, 2025 |
Attar Eyal C.
|
CHIEF MEDICAL OFFICER |
Sell |
90.0
|
+51,147
|
62.80%
|
✗
|
$1.8K |
| Feb 3, 2025 |
Feb 5, 2025 |
Choi Han Wook
|
CFO |
Neutral |
90.0
|
+52,500
|
100.00%
|
✗
|
- |
| Jan 6, 2025 |
Jan 8, 2025 |
Kalir Erez
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 8, 2025 |
Kalir Erez
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 30, 2024 |
Jan 2, 2025 |
Reprogrammed Interchange LLC
|
10% Owner |
Neutral |
90.0
|
+38,974,101
|
100.00%
|
✗
|
- |
|
Jan 2, 2025 |
Reprogrammed Interchange LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 27, 2024 |
Dec 31, 2024 |
Attar Eyal C.
|
CHIEF MEDICAL OFFICER |
Sell |
28.8
|
-10,334
|
-11.26%
|
✓
|
$12.9K |
| Dec 30, 2024 |
Dec 30, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
90.0
|
+16,897,159
|
80.76%
|
✗
|
- |
| Nov 6, 2024 |
Nov 8, 2024 |
Chakraborty Tirtha
|
CHIEF SCIENTIFIC OFFICER |
Sell |
50.0
|
-875
|
-0.51%
|
✗
|
$752.5 |
| Nov 6, 2024 |
Nov 8, 2024 |
Quinlan Amy
|
President |
Sell |
52.5
|
-206
|
-0.41%
|
✗
|
$177.2 |
| Nov 6, 2024 |
Nov 8, 2024 |
Attar Eyal C.
|
CHIEF MEDICAL OFFICER |
Sell |
47.5
|
-999
|
-1.08%
|
✗
|
$859.1 |
| Nov 6, 2024 |
Nov 8, 2024 |
ANG ROBERT
|
CEO |
Sell |
52.5
|
-2,361
|
-0.30%
|
✗
|
$2K |
| Nov 1, 2024 |
Nov 5, 2024 |
Quinlan Amy
|
President |
Sell |
50.0
|
-343
|
-0.67%
|
✗
|
$274.4 |
| Nov 1, 2024 |
Nov 5, 2024 |
Chakraborty Tirtha
|
CHIEF SCIENTIFIC OFFICER |
Sell |
50.0
|
-986
|
-0.57%
|
✗
|
$788.8 |
| Nov 1, 2024 |
Nov 5, 2024 |
Attar Eyal C.
|
CHIEF MEDICAL OFFICER |
Sell |
47.5
|
-1,146
|
-1.22%
|
✗
|
$916.8 |
| Nov 1, 2024 |
Nov 5, 2024 |
ANG ROBERT
|
CEO |
Sell |
52.5
|
-2,751
|
-0.35%
|
✗
|
$2.2K |
| Sep 30, 2024 |
Oct 2, 2024 |
Choi Han Wook
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 2, 2024 |
Choi Han Wook
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 3, 2024 |
Sep 4, 2024 |
Chakraborty Tirtha
|
CHIEF SCIENTIFIC OFFICER |
Sell |
47.5
|
-5,576
|
-3.14%
|
✗
|
$4.6K |
| Sep 3, 2024 |
Sep 4, 2024 |
ANG ROBERT
|
CEO |
Sell |
46.3
|
-12,657
|
-1.57%
|
✗
|
$10.5K |
| Aug 1, 2024 |
Sep 4, 2024 |
Quinlan Amy
|
President |
Sell |
47.5
|
-4,951
|
-8.87%
|
✗
|
$4.2K |
| Aug 6, 2024 |
Aug 8, 2024 |
Attar Eyal C.
|
CHIEF MEDICAL OFFICER |
Sell |
47.5
|
-999
|
-1.05%
|
✗
|
$869.1 |
| Aug 6, 2024 |
Aug 8, 2024 |
ANG ROBERT
|
CEO |
Sell |
52.5
|
-2,361
|
-0.29%
|
✗
|
$2.1K |
| Aug 6, 2024 |
Aug 8, 2024 |
Chakraborty Tirtha
|
CHIEF SCIENTIFIC OFFICER |
Sell |
52.5
|
-876
|
-0.49%
|
✗
|
$762.1 |
| Aug 1, 2024 |
Aug 5, 2024 |
ANG ROBERT
|
CEO |
Sell |
52.5
|
-2,751
|
-0.34%
|
✗
|
$2.6K |
| Aug 1, 2024 |
Aug 5, 2024 |
Attar Eyal C.
|
CHIEF MEDICAL OFFICER |
Sell |
47.5
|
-1,146
|
-1.19%
|
✗
|
$1.1K |
| Aug 1, 2024 |
Aug 5, 2024 |
Chakraborty Tirtha
|
CHIEF SCIENTIFIC OFFICER |
Sell |
50.0
|
-985
|
-0.55%
|
✗
|
$925.9 |
|
Jun 26, 2024 |
Quinlan Amy
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 3, 2024 |
Jun 4, 2024 |
Attar Eyal C.
|
CHIEF MEDICAL OFFICER |
Sell |
28.8
|
-14,645
|
-13.23%
|
✓
|
$20.4K |
| May 23, 2024 |
May 28, 2024 |
Namouni Fouad
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2024 |
May 28, 2024 |
Beckman Daniella
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2024 |
May 28, 2024 |
Lundberg Sven Ante
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2024 |
May 28, 2024 |
Lubner David Charles
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2024 |
May 28, 2024 |
Patterson Matthew R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2024 |
May 28, 2024 |
Resnick Joshua
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2024 |
May 28, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 6, 2024 |
May 7, 2024 |
Jorgensen Nathan D.
|
CFO |
Sell |
52.5
|
-834
|
-0.44%
|
✗
|
$1.5K |
| May 6, 2024 |
May 7, 2024 |
Attar Eyal C.
|
CHIEF MEDICAL OFFICER |
Sell |
50.0
|
-999
|
-0.89%
|
✗
|
$1.7K |
| May 6, 2024 |
May 7, 2024 |
Chakraborty Tirtha
|
CHIEF SCIENTIFIC OFFICER |
Sell |
52.5
|
-875
|
-0.49%
|
✗
|
$1.5K |
| May 6, 2024 |
May 7, 2024 |
ANG ROBERT
|
CEO |
Sell |
52.5
|
-2,361
|
-0.29%
|
✗
|
$4.1K |
| May 1, 2024 |
May 3, 2024 |
ANG ROBERT
|
CEO |
Sell |
52.5
|
-2,751
|
-0.34%
|
✗
|
$4.9K |
| May 1, 2024 |
May 3, 2024 |
Attar Eyal C.
|
CHIEF MEDICAL OFFICER |
Sell |
47.5
|
-1,146
|
-1.02%
|
✗
|
$2K |